Interview: Frans Labuschagne – Head of Pharma, Bayer South Africa
The head of pharma for Bayer Southern Africa reveals how South Africa plays a key role in Bayer’s African strategy, with more than 60 percent of the continent’s total sales,…
Address: Suite 2 Building 4 Ruimsig Office Estate, Hole in One Avenue, Ruimsig, 1724 Roodepoort, Gauteng, South Africa
Tel: +27-11-9582168
Web: http://www.tevapharm.com/Pages/default.aspx
Established in 1901, Teva takes great pride in its long tradition of leadership and dedication to excellence.
Teva is a global generic pharmaceuticals leader and one of the top 15 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 47,000 employees worldwide.
Established in 1901, Teva takes great pride in its long tradition of leadership and dedication to excellence.
Teva specializes in development, production and marketing of a wide range of generic and branded products, as well as active pharmaceutical ingredients (API).
For over a century, Teva has maintained a distinct competitive edge through:
High quality offerings
Focus on customers and patients
Balanced product portfolio (both generic and innovative)
Integration of pharmaceutical and API activities
Combination of global operations with local customer responsiveness
Established international presence through a tailored network of worldwide subsidiaries
Teva aims to be the first to introduce the highest quality standards and the most competitive prices.
Teva’s branded products make a significant difference in people’s lives. We leverage our large-scale operations, scientific resources and global leadership to develop and produce drugs that are tailored to address patients’ needs.
Only the highest quality standards are implemented to ensure our customers’ wellbeing. As our branded business expands, we continue to explore new areas and exciting platforms, in pursuit of new products that can enhance your quality of life.
The head of pharma for Bayer Southern Africa reveals how South Africa plays a key role in Bayer’s African strategy, with more than 60 percent of the continent’s total sales,…
The CEO of Pharma Dynamics explains why the company was the perfect match for Lupin, as the fastest growing, and largest independently owned acquirable pharmaceutical business in South Africa, why…
The chairman of PHARMISA reveals how pharmaceuticals has been designated as one of eight priority sectors of South African Government’s Industrial Policy Action Plan (IPAP), how South African life expectancy…
The CEO of Pierre Fabre for South Africa reveals how his focus has been on marketing the company brand locally, why the goal of the company is to develop business…
The EO of SAMED discusses recent regulations surrounding the medical device industry in South Africa, why South Africa remains the hub and the major gateway to Africa for medical devices…
The managing director of UTi Pharma reveals how UTi is no longer just an international forwarding company but covers a broad spectrum of activities; why as global business increases it…
The MD of Triclinium Clinical Development discusses how South Africa’s established First and Third World research opportunities and long-established GCP culture have made it a uniquely attractive country for clinical…
The country manager for BMS South Africa talks about the company’s first to market strategy, and how BMS has shifted the treatment paradigm for oncology in South Africa. Through our platform, we introduce the…
Iain Barton reveals how the acquisition of RTT Medical by IHS in 2013 has allowed Imperial to become the biggest pharma supply chain and general logistics services player on the African…
Peter Fuller provides us with an update on the integration of Covidien businesses, and explains how Medtronic is bringing innovation to South African patients and contributing to the improvement of the…
Adv. Leslie Sedibe, CEO of Proudly South African explains how the Proudly South African campaign aims to promote local products and services to ultimately address unemployment, and what his main…
The country president of Novartis South Africa reveals how Novartis has recently moved to new premises, demonstrating a clear commitment to continue investing in the country; why South Africa…
See our Cookie Privacy Policy Here